Since about 2002, progress in understanding and developing techniques for modulating immune system function so as to significantly suppress the action of macrophages to drive atherosclerotic plaque progression are being developed with considerable success in reducing plaque development in both mice and rabbits. Plans for human trials, hoped for by about 2008, are in progress. Generally these techniques are termed immunomodulation of<unk> .
Atherosclerosis future or investigational therapies
Deep vein thrombosis future or investigational therapies
Peripheral arterial disease primary prevention
High density lipoprotein future or investigational therapies
Cirrhosis future or investigational therapies
Osteoporosis future or investigational therapies
High cholesterol primary prevention
Atherosclerosis medical therapy